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The aim of this research was to ascertain General Practitioners’ (GPs) 
perceptions and experiences of prostate cancer (PCa) diagnosis, treatment, and 
care in metropolitan Melbourne and in a regional area of Victoria, Australia, 
associated with poorer PCa outcomes. Semi-structured qualitative interviews 
were conducted with GPs (N= 10) practising in the selected region and in 
metropolitan Melbourne, Australia. GPs thought that most men wanted PSA 
testing and were willing to undergo rectal examination. Some GPs were 
troubled by inconsistent screening guidelines from different professional 
bodies. They identified a need for resources to support them in educating 
patients about PCa. GPs thought it might be more difficult for young female 
GPs to care for patients in relation to PCa screening; differences were evident 
between younger female GPs and older male GPs in the approach they adopted 
in interviews. Regional GPs often referred patients to services in larger centres 
because no local specialists were available. GPs also found it hard to explain 
differences in PCa outcomes in regional and metropolitan areas. Potential age 
and gender differences in GPs in relation to prostate care warrant further 
examination. Although GPs were able to offer only limited insights into the 
poorer outcomes in regional areas, they identified ways in which they could be 
assisted to provide best-practice care. Multidisciplinary care, resources for 
patients, and consistent guidelines for the detection and treatment of PCa 
should contribute to better care in all areas. Keywords: Prostate Cancer, 
General Practitioners, Regional, Screening, Diagnosis, Care, Qualitative 
Research 
  
Prostate cancer (PCa) is the most commonly diagnosed and prevalent tumour reported 
to cancer registries in Australia and globally (Smith et al., 2009; Evans et al., 2013). While 
long term survival following a diagnosis of PCa is relatively good (~92% at 5 years), there is 
considerable morbidity associated with the treatment and management of PCa. Survival differs 
according to disease stage at diagnosis. There is evidence that patients with locally advanced 
disease (as denoted by a prostate specific-antigen [PSA] level of greater than 10ng/mL, local 
histologic findings, and stage) will benefit from surgical treatment compared with men who 
have no active treatment (Wilt et al., 2012). Health-related quality of life (QoL) outcomes after 
treatment are of critical concern to patients, their partners, and physicians (Glaser et al., 2013; 
Lev et al., 2004; Skevington & McCrate, 2012; Smith et al., 2009; Storas et al., 2014; Wei et 
al., 2002). 
It is important to detect prostate cancer as early as possible to enable optimum outcomes 
and potential cure. General Practitioners (GPs) are often the first health professionals to hold 
discussions with men about whether to undertake screening of PCa and, following diagnosis, 
which treatment to choose. A key role of GPs is to ensure that screening and treatment options 
2366   The Qualitative Report 2016 
have been explained to and understood by the patient and to act as the patient’s advocate in 
choosing the most appropriate treatment.  
GPs are usually also involved in post-treatment care, including managing 
comorbidities, monitoring disease recurrence and side-effects of treatment, and provision of 
psychosocial support. According to Emery (2014), good “survivorship” care requires clear 
channels of communication among the specialist, GP, and patient. The provision by GPs of 
good communication, clear guidance, and access to specialist care may reduce the reliance on 
specialists by many cancer survivors. Longitudinal data from the UK on nearly 5000 survivors 
with PCa (alive at least 5 years post diagnosis) showed that survivors consulted their GP up to 
three more times annually compared to healthy controls matched on the basis of age, sex, and 
primary care practice (Khan, Watson, & Rose, 2011). A similar study in the Netherlands 
showed that men with PCa see their GP more than controls at 2–5 years after diagnosis for both 
cancer-related health problems and disease management (Heins, Korevaar, Rijken, & 
Schellevis, 2013). 
Previous studies have revealed high variability in PCa screening habits and techniques 
amongst GPs (Crowe, Wooten, & Howard, 2015; Drummond , Carsin, Sharp, & Comber 2009; 
Bowen, Hannon, Harris, & Martin, 2011; Tasian et al., 2012). Broadly, PCa screening 
approaches can be classified into two categories: (1) GPs who routinely scan patients they 
believe to be at risk of PCa, and (2) GPs who scan patients in response to a request or to a 
patient’s troubling symptoms (Drummond et al. 2009; Bowen et al. 2011; Crowe, Wootten, & 
Howard, 2015). Many factors might contribute to this variability. Bowen et al. (2011) noted 
that common concerns among GPs not detecting PCa at an early stage included the resulting 
legal ramifications and/or mortalities. Another concern possibly contributing to variability in 
PCa screening habits was GPs’ lack of clarity about when screening for PCa is appropriate 
(Crowe, Wootten, & Howard, 2015; Drummond et al., 2009).  
Variability in clinical guidelines in Australia and overseas is also believed to contribute 
to GPs’ inconsistent screening techniques (Bowen et al. 2011; Crowe, Wootten, & Howard, 
2015; Drummond et al., 2009; Jessen, Sondergaard, Larsen, & Thomsen 2013). Identified 
causes of deviations from established PCa screening guidelines potentially include 
insufficiently clear guidelines, patient requests for screening, past experience with men 
diagnosed with PCa, various co-morbidities, and the fear of litigation by and mortality of men 
with PCa.  
An association between elevated incidence rates of prostate cancer and poorer 
awareness of the disease have been found in regional areas in the US, along with men’s 
misconceptions about prostate cancer and a tendency not to discuss the topic with their GPs 
(Sanderson, Wijesinha, & Jones, 2013). Men in Australia have also been found not to raise the 
topic with their GP, even when they are aware of a family history of PCa (RACGP, 2012). 
According to the Royal Australian College of General Practitioners (RACGP) Guidelines, 
developed for use by GPs in Australia, PCa screening is not recommended unless the man 
specifically requests it (“Screening for prostate cancer is not recommended unless: 1. The man 
specifically asks for it; and 2. he is fully counselled on the pros and cons”) (RACGP 2012). 
Thus, if men do not raise the topic of PCa and GPs follow the RACGP’s Guidelines, it is 
possible that prostate cancer will not be discussed.  
Residents of rural and remote communities in Australia have poorer health outcomes 
than metropolitan residents (Baade, Youlden, Coory, Gardiner, & Chambers, 2011; Coory & 
Baade, 2005; Henry et al., 2014; Obertová, Hodgson, Scott-Jones, Brown, & Lawrenson, 
2016). There is limited evidence of the degree to which GPs raise the topic of PCa screening 
and care, including in regional and rural areas where men may have limited access to healthcare 
services. Despite recent regional health initiatives in Australia, the healthcare needs of many 
regional communities are still not adequately met (Humphreys & Wakerman, 2008).  
Rasa Ruseckaite et al.                       2367 
In summary, we know that GPs are important in the detection of prostate cancer and in 
the care of men diagnosed with prostate cancer. It is recognised internationally that GPs may 
be uncertain about when screening is appropriate and that men may not raise the topic with 
their doctors. We also know that men in regional areas often have poorer health outcomes than 
men in metropolitan areas, including in Australia where our research was conducted. In 
research in which some of us were engaged, we were concerned to discover differences in care 
and treatment outcomes for men diagnosed with PCa between one Victorian regional area and 
metropolitan Melbourne (Ruseckaite, Sampurno, Millar, Frydenberg, & Evans 2016). This area 
covers more than 18% of Victoria’s total landmass. In 2011, the region’s estimated resident 
population was 270,512 and represented ~5% of Victoria’s total population (ABS 2015). By 
2026, its population is projected to increase by 21% compared with an overall state average 
increase of 23%. This region incorporates 16 health services. Men in the region are more likely 
to be diagnosed at an older age with more advanced disease and to have a longer time interval 
between diagnosis and treatment (Ruseckaite, Sampurno, Millar, Frydenberg, & Evans, 2016). 
There are no local explanations for these discrepancies.  
Given the significance of GPs in prostate cancer detection and care, we decided to seek 
the views of GPs practising in regional and metropolitan Victoria, drawing on the wider 
literature to inform our consultations with them. Our aim was to ascertain GPs’ perceptions 
and experiences of PCa diagnosis, treatment, and care and their explanations for the observed 
regional-metropolitan discrepancy. It was planned that the results would contribute to 
improving policy and practice in Australia, not only by informing medical practitioners but 
also through our links with Prostate Cancer support and fundraising groups. Given the 
international observations of differences in prostate cancer care and outcomes according to area 
of residence, we hoped that our work would be relevant to a wider audience of people 
concerned with men’s health. Because our research questions concerned experience, meaning 
and perspective from the participants’ standpoint, a qualitative approach was essential 
(Hammarberg, Kirkman, & de Lacey, 2016). Because we had specific topics we wanted to 
explore, semi-structured interviews were the most appropriate technique to choose (Smith, 
1995).  
 
Method 
 
The Research Team 
 
We are a multidisciplinary group of researchers and clinicians working in public health 
in a major Australian university. This research was initiated when troubling data were 
identified in the large multinational PCa clinical quality registry led by SE (a clinical 
epidemiologist) and JM (an oncologist). The registry team approached DM, as head of the 
Department of General Practice, to contribute her expertise in the work of GPs. RR is a 
quantitative research specialist who was part of the team working on the registry data and who 
conceived of the idea of consulting GPs. The team brought in SH, JF, and MK as experts in 
psychosocial research and qualitative research methods. All authors contributed to the design 
of the research and interpretation of the results. SH conducted the interviews with GPs. Team 
members are committed to a social model of health and seek evidence that will contribute to 
health and wellbeing: in this case, of men who have been or might be diagnosed with prostate 
cancer. We are planning the next stage of research to extend our knowledge beyond Victoria 
and to include partners and informal careers of men with prostate cancer. 
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Eligibility, Recruitment, and Data Collection 
 
GPs were eligible for inclusion if they practised in the identified regional area or in 
metropolitan Melbourne, Australia. Because this research was designed to illuminate large-
scale epidemiological data and not to initiate a phenomenological investigation, it was expected 
that interviews with 10 GPs would provide the information sought. GPs were invited to 
participate in the research by emails and letters distributed to clinics. Invitations were sent to 
50 general practices in the selected study area and to 50 general practices in metropolitan 
Melbourne with contact details available online. Participant Information and Consent 
documents were sent to GPs who contacted the researchers to express interest in participating. 
The first 10 volunteers were accepted for interview. Because interviews were conducted during 
consultation hours, GPs were reimbursed $200, reflecting the average hourly consultation rate.  
Our choice of semi-structured qualitative interviews, while focusing on particular 
aspects of a topic, does not confine participants to response categories defined in advance by 
researchers and is particularly appropriate when there is limited evidence on a phenomenon 
(Hammarberg et al., 2016). We developed the interview guide using the questions that 
prompted the research and our knowledge of the literature. Our open-ended questions asked 
GPs about their experience of prostate consultations, screening, diagnosis, and referral, as well 
as their reflections on regional differences and barriers, and enablers in prostate care. We also 
invited them to comment further on any topic they thought was important to men with prostate 
cancer and the role of GPs. 
A member of the research team (SH) conducted interviews by telephone during March 
to June 2015 in Victoria, Australia. GPs gave oral consent at the beginning of the interview.  
 
Data Management and Analysis 
 
We audio-recorded the interviews (with permission from interviewees). An experienced 
transcriber who had signed a confidentiality agreement transcribed the recordings verbatim. 
SH and MK analysed the transcripts thematically using a well-established method (Braun & 
Clarke, 2006). We first categorised responses to the themes implicit in the questions, then 
searched for any new themes raised by interviewees. Four members (RR, MK, SH, and JF) of 
the research team negotiated and finalised the emerging thematic structure; SH and MK 
rechecked the transcripts to ensure that the analysis was accurate and comprehensive. The team 
discussed and agreed on the interpretation and selection of exemplary quotations. Approval to 
conduct this research was granted by the Monash University Human Research Ethics 
Committee.  
 
Results 
 
Each interview took from 15 to 30 minutes to complete. In our analysis of the 
transcripts, we identified four major themes arising from the questions we asked of GPs: the 
relevance of GP gender and age; men’s awareness of PCa and of PCa screening initiatives; the 
role of the GP in PCa screening; GPs’ information needs and their assessment of guidelines; 
and potential regional differences. We were unable to identify any additional themes. Before 
presenting details of each theme, we summarise characteristics of the participating GPs.  
 
The General Practitioners 
 
Four of the interviewed GPs practised in the regional area and six in metropolitan 
Melbourne. There were six female GPs and four male GPs. The women tended to have 
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qualified more recently (average 16 years since graduation) and thus to be younger than the 
men (average 33 years since graduation). The number of men with prostate cancer that GPs 
reported seeing each year ranged from two to 30; most GPs saw about two or three men with 
PCa. On average, GPs thought that about 10% of their male patients were at risk of PCa. Details 
of individual GPs have not been tabulated to maintain confidentiality.  
 
GP Gender and Age 
 
In general, GPs assessed PCa screening as varying according to characteristics of the 
GPs themselves, particularly their age and sex. Older, male GPs tended to be perceived as being 
more comfortable discussing or performing digital rectal examinations than younger, female 
GPs: 
 
I think, like a lot of practices, it really depends on the demographics of the 
doctors at the time, so I think our prostate cancer care was much better when we 
had a 55-year-old [male] GP working here. So I have to say that I think that 
decreased when he left the practice. (Regional GP, female) 
 
Some GPs also thought that men can be uncomfortable consulting a young female doctor about 
PCa screening, especially when they knew that it could result a digital rectal examination. 
These views came from women and men and referred also to GPs’ embarrassment (as in the 
first example) and disgust (as in the second). 
 
I think some females might be reluctant to do the DR [digital rectal] exam, and 
understandably so if it’s awkward. And yeah, it can be awkward in the situation 
of a younger female GP if the man accidentally has an erection when you’re 
doing that; that’s just a bit worrying and embarrassing. But if you don’t think 
about it and just go ahead and just get it out of the way, it should be fine. 
(Metropolitan GP, female) 
 
The main barrier, I think, is the yuck factor that goes with the digital rectal test. 
Men don’t like it and, to a certain extent, also I think some doctors don’t like to 
do it. And I suspect, too, that if you’re a female GP, your threshold for doing it 
is higher. I’m not entirely certain of that, but it’s just the gut feeling I have, that 
a number of digital rectal exams done by female GPs would be less than that 
done by myself. (Metropolitan GP, male) 
 
Analysis also revealed notable differences between the women and men interviewed. It 
is important to keep in mind that gender differences are confounded by age differences, with 
the women being, on the whole, more recently qualified than the men. 
The male GPs presented themselves as more confident with PCa screening than the 
women, which could be attributable to their longer experience. The women were more likely 
to report seeking advice from a urologist about PSA test results and other aspects of testing and 
diagnosis, and to say that they would welcome more information. The contrast is seen in the 
following two quotations: 
 
I would usually get phone advice with a PSA that was raised. So I’d usually get 
some phone advice, or repeat it, and then if it was persistently raised or going 
up, then I would refer, even just for an opinion. (Regional GP, Female) 
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I would say, “… There are few ways we can screen this. We can do it by blood. 
We can do it by finger in the back passage,” but I don’t try to push for the blood 
testing. I explain to them, “Look, blood testing is a great way to test for PSA, 
and don’t think that if your blood tests are fine, you’re off the hook.” So I raise 
that from about 45 onwards, and I might agree with them that we’ll start formal 
assessment, formal screening at 50 up, unless the family history points me to 
doing it earlier. Or if they’re very insistent that they get a PSA at the age of 42, 
I’ll do it for them, but I’ll tell them it’s not necessarily a great test. … My 
personal view is that the PSA is not a good test, and the finger up the back 
passage is also not a great test. … I think that one day we will move to a better 
way of screening for prostate cancer. (Metropolitan GP, Male) 
 
Differences were also noted in the types of responses and language used by female and 
male GPs. The women were careful, formal, and respectful in their language. Where male GPs 
were inclined to use more informal, “blokey” terms, such as “finger up the bum.” female GPs 
referred to “rectal examinations.”  
 
Men’s Awareness of PCa and Initiatives 
 
GPs thought that, on the whole, men wanted to have a PSA test and were willing to 
have a rectal examination, telling the GP to “just do it” or “get it over with.” This could be 
characterised as satisfaction with a doctor’s professional attention (as in the first example) or 
compliance with a doctor’s insistence (as in the second).  
 
They seem very happy that someone is concerned about their health. 
(Metropolitan GP, female) 
 
Most [men] are very keen to do the blood test. Not so many are so keen to have 
the finger in the passage. Nonetheless, if you push the point, and you sort of 
really want to do it, they won’t generally say “no” either. (Metropolitan GP, 
male) 
 
However, GPs also commented that some men may not raise the topic of PCa screening, 
either because it does not occur to them or because of active reluctance, and that others prefer 
not to be tested because they are concerned about the possibility of a false positive or false 
negative result. Several GPs contrasted PCa screening with active management of women’s 
health: 
 
[Unlike] women who come in and say, “I’m here for my Pap smear,” men don’t 
say, “I’m here to talk to you about prostate cancer.” The only people who ever 
do that are those with a very strong history of prostate cancer. (Metropolitan 
GP, male) 
 
GPs thought that men would benefit from seeing flyers, posters, and other material 
about PCa in GPs’ waiting rooms, designed to act as reminders to ask the GP about their risk 
of PCa and the need for checks:  
 
When people are sitting there waiting, and they’re just staring at other people, 
perhaps they could stare at the poster instead to remind them, “Have you had 
any prostate symptoms, such as this, this, and this, and please bring that up 
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during your consultation.” Because then people would, people often respond to 
all sorts of posters, even things that you think no-one would be interested in. 
But someone will say, “I just saw that poster outside,” and they want to talk 
about it. So I think a poster is a very quiet but powerful way, and a very cost-
effective way, of bringing that up. (Metropolitan GP, female) 
 
In regional and rural areas, it was suggested that educational material about PCa could 
be provided throughout the community, such as in sports clubs and “men’s sheds,” established 
as part of the health infrastructure that supports programs to improve men’s health and 
wellbeing in Australia, because it was thought that men outside metropolitan areas tend not to 
have regular visits to the GP. 
 
GP’s Role in PCa Screening 
 
Most of those interviewed said that GPs had a primary role in the screening and 
diagnosis of PCa. This was evident in metropolitan and regional areas and was mentioned by 
female and male GPs: 
 
GPs should be proactive to think about it, much like when we think about Pap 
smears and breast exams for females. (Metropolitan GP, female) 
 
You’re the first port of call, and, if you can prompt it, and the patient is agreeable 
for further investigations, I think that’s the most important thing for a GP to do: 
first of all to raise the issue, and then to do something about it. (Regional GP, 
male) 
 
GPs reported taking action in relation to PCa screening depending on men’s age and 
whether they had a family history of PCa:  
 
I usually ask them whether or not they’ve got any risk factors, so family history, 
and if they do, or if they’ve got any—and then I usually ask if they’ve got any 
concerns about prostate cancer, if they particularly want to be screened or not, 
and then I will talk to them about prostate screening, having a PSA and a rectal 
examination, and inform them that the PSA is a screening test that can miss 
prostate cancers, and that you can also get false positives with it, and I use that 
information with their previous PSAs to make a decision about whether or not 
they think, for them to make an informed decision about whether or not they 
have screening. None of my patients have screening without, I guess, that 
discussion. (Regional GP, female) 
 
Female GPs in particular tended to approach PCa screening as part of a routine yearly general 
and preventative health check for men aged over 50: 
 
It’s not just when someone comes in, or when the wife drags them in, but when 
they’re here for something else, I tend to just bring it up. (Metropolitan GP, 
female) 
 
Our patients are usually pretty well trained to come in every 12 months for 
preventative health care, and it’s usually discussed at that point, so at least 
annually. (Regional GP, female) 
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There were some suggestions that GPs could take more initiative in broaching the topic 
of PCa:  
 
GPs could be asked to be a bit more proactive about asking the questions, and 
don’t feel shy about asking these questions. Because it’s like asking the crisis 
patient about suicide attempts, because we were shy to ask about suicide, but 
now we don’t. We just ask them a straight question: “Have you any suicidal 
thoughts?” It’s the same with the prostate cancer. We can ask them, “Do you 
have any prostate issues? Do you have any problems waking up at night for 
going to the toilet?” All those sorts of things you can ask them. (Regional GP, 
male) 
 
GPs felt that they had a “supportive role” following a definitive treatment that included 
providing information or advice. 
 
Sometimes the message is not conveyed clearly across in that stressful situation 
[appointments with specialists], so allowing the patient to come in and reading 
the correspondence with them, and guiding them through the next steps, would 
be my main role. (Regional GP, female) 
 
The support also included helping men to manage side-effects of treatment, especially 
sexual and erectile dysfunction. However, GPs reported experiencing difficulty in identifying 
the ramifications of prostate cancer for men’s wellbeing. Few said that they had encountered 
patients with mental health problems; these GPs described men as getting “pretty depressed 
about it” and said that they referred such men to psychologists or counsellors. 
 
GPs’ Information Needs and Guidelines 
 
Although GPs asserted the importance of their role in PCa screening, they described 
several barriers to best practice, including time constraints: 
 
[Some GPs] wouldn’t be bothered to [educate men] anyway because of the time 
factor. (Regional GP, female) 
 
GPs also called for more resources to keep them professionally up to date and to educate 
men: 
 
[We need] easy printout material … in a brochure form or something to give to 
the patient. (Regional GP, female) 
 
[I would like] more literature, and recent data or publications. (Metropolitan 
GP, female). 
 
They reported seeking guidance from urologists about PSA parameters and frequency: 
 
I tend to make lots of phone calls to urologists about—and I don’t feel confident 
to make any decisions about—at the moment, I get to the point where I don’t 
really feel confident in making a decision about any PSA results. (Regional GP, 
female) 
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GPs were not always confident about what constituted best practice: 
 
My understanding keeps shifting every so many years, because there is always 
this perennial debate about whether we do it the US way or the UK way. 
(Metropolitan GP, male) 
 
GPs said that they found conflicting advice in guidelines, such as from the RACGP, the 
Australian College of Pathologists, and the Australian College of Urologists, that left them 
“confused” about which patients to screen and when. They requested unequivocal guidance on 
which they could act: 
 
I think we need much more clear guidelines as to whether we go the PSA 
pathway or the digital rectal exam pathway. I know that one college, the College 
of Pathologists, traditionally has said one thing, and then the College of GPs has 
said another. (Metropolitan GP, male) 
 
Regular briefings or seminars for GPs about PCa screening, including which men to 
screen and how to encourage participation, were identified as important sources of support:  
 
Now that you’ve quizzed me on some of this, I’ve kind of realised how limited 
my knowledge is. So I think it’s good for us to get a bit more education. 
(Metropolitan GP, female) 
 
The role of researchers in drawing participants’ attention to a taken-for-granted or 
previously unconsidered topic is evident in the previous quotation. 
 
Regional Differences 
 
There were obvious differences in metropolitan and regional referral availability. GPs 
were aware that their colleagues practising in metropolitan areas have access to private 
urologists for referral, whereas regional GPs tended to have to refer patients to services (usually 
public) in larger centres, commonly located in Melbourne or Canberra, two to eight hours 
driving distance away. Nevertheless, few GPs were aware that there are regional differences in 
PCa mortality rates. It was a challenge for them to suggest possible reasons for higher mortality 
rates in regional Victoria than metropolitan Melbourne. Female GPs and those who had worked 
in regional or rural areas were most likely to propose explanations, of which there were four. 
The first potential explanation was that men in rural areas are less likely to visit a GP, 
with an approach that one metropolitan female GP characterised as, “Be tough, and don’t go 
get your health checked.” Another metropolitan female GP said, 
 
I think maybe we [metropolitan GPs] do a lot more screening and pick it up 
earlier. … Yeah, just simply seeing your GP a bit more often, although guys 
don’t see GPs as often as women, but they still see them more than someone 
else living out in a rural area, and so, because of that, you would probably have 
a higher chance of getting your PSA checked, and your prostate as well. 
(Metropolitan GP, Female) 
 
The regional perspective also asserted men’s relaxed attitude to their health: 
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[In this rural community], I think that’s one of the major problems, that men, 
and normally, generally are less worried about their health. They have some 
issue, they say, “Oh, it’s okay,” and then they just get on with their work, and 
they don’t go to the doctor, really, easily. I think that’s the major problem why 
these things are not diagnosed early. (Regional GP, Male) 
 
The second proposed explanation was that it is more difficult for men in rural or 
regional areas to access services; patients have to travel to distant cities to see a urologist. 
 
I did study in the country, and I did find that, if anything, the males were maybe 
even more recalcitrant about presenting. There’s less access to primary care, 
and also less access to specialists and imaging and treatment. I guess it would 
probably influence treatment decisions if they might have to travel a long way 
for whatever they decide to do. And even, I guess, some of the watch-and-wait 
ones, it might be they have to travel a while to have the investigations. So it 
might be, yeah, it might change the management there. I think access would be 
a big thing, and maybe health-seeking behaviour. (Metropolitan GP, Female) 
 
A third explanation suggested by GPs was that men in small communities may be 
uncomfortable having a rectal examination from their GP who may also be someone they know 
socially. 
 
The reason why is because country folk—look, you’ve only got a small number 
of GPs. They know you very well. They’ve probably known you for a very long 
time, and it’s maybe just a tad too intimate to somebody you know very well 
offering to put a finger up your bottom. In the metropolitan areas, you’ve often 
got two to three to four to five GPs under the same roof, and it’s easier to go to 
that other GP and have him do that, and then go back to your usual GP. But I 
don’t think in regional areas you’re going to have that choice. So the threshold, 
the barrier for doing these things is raised. It gets done at some point, but later 
than usual, by which time the cancer is a bit more advanced than usual, and 
therefore it will reflect itself in the mortality stats. (Metropolitan GP, Male) 
 
Finally, it was suggested by one GP that higher regional mortality rates were indirectly 
caused by the freedom of men to urinate out of doors.  
 
The only one [reason for higher mortality rates] I can think of is the fact that 
often a lot of men who are working outside, especially if they’re in the bush, 
tend to have much poorer bladder control generally, because they just wee 
wherever they want. … It’s quite common for farmers to have early lower 
urinary tract symptoms. (Regional GP, Female) 
 
Suggestions for interventions to reduce the regional mortality rate did not extend 
beyond education, information, and publicity; it was seen as an intransigent problem: 
 
I guess to reduce [regional prostate cancer mortality rates] would be difficult, 
because, as we know, it’s more to do with family history and age; those are 
unmodifiable. (Regional GP, Female) 
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Discussion 
 
This investigation, in which GPs were consulted about prostate cancer screening and 
care, revealed potential ways to support GPs that could improve practice overall, not just in 
regional areas with poorer survival outcomes for men with prostate cancer. 
Our results about GPs’ roles and needs are consistent with the limited relevant 
literature, which confers face validity. GPs’ endorsement of their primary role in screening, for 
example, echoes the results of Brett et al. (2005) from GPs in regional and metropolitan areas 
in the UK. In common with Australian research by Ilic, Murphy, and Green (2013), we found 
that GPs were aware of benefits and limitations in current screening tools; we also found that 
GPs wanted to be kept up to date with research and advised on how to translate it into practice. 
It has been noted elsewhere that cancer care in rural and regional Australia is fragmented, with 
rural and regional patients having less access to health services (Baade et al., 2011). The 
relative isolation of GPs in regional areas could be contributing to poorer outcomes of men 
with prostate cancer (Rao, Manya, Azad, Lawrentschuk, Bolton, Davis, & Sengupta, 2014). 
Potential age and gender differences identified by and in GPs in relation to prostate care, as 
also found by Gattellari, Young, and Ward (2003), warrant further examination.  
Although GPs were able to offer only limited insights into the poorer outcomes in non-
metropolitan areas, they identified ways in which they could be assisted to provide best-
practice care. Principal among these was the need for consistent guidelines on PCa screening, 
a need also noted elsewhere (Ranasinghe et al., 2015). In the meantime, GPs can be encouraged 
to make use of the Optimal Care Pathways developed by the National Cancer Expert Reference 
Group which was established by the Council of Australian Governments in 2010 (Department 
of Health, 2012). These pathways act as a reminder that the patient is the constant in this 
journey and that the health system has a responsibility to deliver care in an appropriate and 
coordinated manner. 
The qualitative approach is a major strength of this study. The semi-structured 
interviews enabled GPs to reflect on and discuss their work in a nuanced way not amenable to 
counting and measuring. The main limitation is the small sample size. However, the 
remarkably similar commentary from GPs on their needs and concerns contributes to 
understanding how improvements can be made and provides a valuable base for further 
research. The consistency between our results and previous research suggests that our research 
can contribute to building a picture of regional and metropolitan prostate cancer care in 
Australia and elsewhere.  
In particular, this research contributes to identifying the need to strengthen 
communication among GPs, specialists, and consumers (Rüesch et al., 2014). Management of 
patients with cancer by multidisciplinary teams is recognised internationally as best practice 
(Carter, Garside et al., 2003). State and regional health services, therefore, should promote and 
resource multidisciplinary teams to support, communicate with, and guide GPs and their 
patients newly diagnosed with prostate cancer. Multidisciplinary teams, consistent guidelines 
for the detection and treatment of prostate cancer, and better communication have potential to 
contribute to better prostate care in all geographic areas. 
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